Remove Drugs Remove Fragment Screening Remove Pharmacokinetics Remove Trials
article thumbnail

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

PerkinElmer

Inhibiting SARS-CoV-2 Proteases Currently, limited therapeutic options are available to those who are infected with SARS-CoV-2 and attempts to repurpose approved drugs have shown minimal success so far. 2 PF-07321332, which is now being tested in clinical trials, 3 is a nitrile-containing derivative of PF-00835231.